![EISAI ANNOUNCES COMMENCEMENT OF OPERATIONS OF A NEW RESEARCH FACILITY AT H3 BIOMEDICINE INC., A U.S. RESEARCH SUBSIDIARY TO FACILITATE CUTTING-EDGE CANCER GENOMICS-DRIVEN DRUG DEVELOPMENT | News Release:2011 | Eisai Co., Ltd. EISAI ANNOUNCES COMMENCEMENT OF OPERATIONS OF A NEW RESEARCH FACILITY AT H3 BIOMEDICINE INC., A U.S. RESEARCH SUBSIDIARY TO FACILITATE CUTTING-EDGE CANCER GENOMICS-DRIVEN DRUG DEVELOPMENT | News Release:2011 | Eisai Co., Ltd.](https://www.eisai.com/news/images/enews201177-1.jpg)
EISAI ANNOUNCES COMMENCEMENT OF OPERATIONS OF A NEW RESEARCH FACILITY AT H3 BIOMEDICINE INC., A U.S. RESEARCH SUBSIDIARY TO FACILITATE CUTTING-EDGE CANCER GENOMICS-DRIVEN DRUG DEVELOPMENT | News Release:2011 | Eisai Co., Ltd.
![adidas winter shoes for kids boots for women 2017 - Arena Nose Clip Pro Ii Training Tools Ροζ 003792 - 900 adidas winter shoes for kids boots for women 2017 - Arena Nose Clip Pro Ii Training Tools Ροζ 003792 - 900](https://www.sportsfactory.gr/2160335-product_medium/arena-nose-clip-pro-ii-training-tools.jpg)
adidas winter shoes for kids boots for women 2017 - Arena Nose Clip Pro Ii Training Tools Ροζ 003792 - 900
Maria Koukiadi - Freelance Translator - freelance translator, editor and proofreader English-Greek & Greek-English | LinkedIn
![Eisai will shift U.S. HQ to New Jersey 'bio-ecosystem' in move to boost oncology, neurology portfolios | Fierce Pharma Eisai will shift U.S. HQ to New Jersey 'bio-ecosystem' in move to boost oncology, neurology portfolios | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1597159939/1.jpeg/1.jpeg?VersionId=t6UcLxDkMNVV_Myb_obXcMB302Ly1O5Z)
Eisai will shift U.S. HQ to New Jersey 'bio-ecosystem' in move to boost oncology, neurology portfolios | Fierce Pharma
![Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate infectious disease in developing countries | Infectious Diseases Research & Development | Eisai Co., Ltd. Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate infectious disease in developing countries | Infectious Diseases Research & Development | Eisai Co., Ltd.](https://www.eisai.com/sustainability/atm/innovation/images/008_img_01.jpg)